This report aims to provide a comprehensive presentation of the global market for Cell-Based Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-Based Immunotherapy. This report contains market size and forecasts of Cell-Based Immunotherapy in global, including the following market information:
Global Cell-Based Immunotherapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cell-Based Immunotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Autologous Cellular Immunotherapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cell-Based Immunotherapy include Novartis, Gilead Sciences, AbbVie, Bristol-Myers Squibb, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim and Eli Lilly and Company, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell-Based Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell-Based Immunotherapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cell-Based Immunotherapy Market Segment Percentages, by Type, 2022 (%)
Autologous Cellular Immunotherapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy
Dendritic Cell-based Vaccine Therapy
Global Cell-Based Immunotherapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cell-Based Immunotherapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Global Cell-Based Immunotherapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cell-Based Immunotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell-Based Immunotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cell-Based Immunotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Gilead Sciences
AbbVie
Bristol-Myers Squibb
Amgen
AstraZeneca
Biogen
Boehringer Ingelheim
Eli Lilly and Company
GSK
Pfizer
Roche
Takara Bio
Bausch Health
Apac Biotech
Dendreon Pharmaceuticals (SanPower)
JW CreaGene
Green Cross Corp
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cell-Based Immunotherapy, market overview.
Chapter 2: Global Cell-Based Immunotherapy market size in revenue.
Chapter 3: Detailed analysis of Cell-Based Immunotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cell-Based Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cell-Based Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell-Based Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell-Based Immunotherapy Overall Market Size
2.1 Global Cell-Based Immunotherapy Market Size: 2022 VS 2029
2.2 Global Cell-Based Immunotherapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell-Based Immunotherapy Players in Global Market
3.2 Top Global Cell-Based Immunotherapy Companies Ranked by Revenue
3.3 Global Cell-Based Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 Cell-Based Immunotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell-Based Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell-Based Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 Cell-Based Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell-Based Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell-Based Immunotherapy Market Size Markets, 2022 & 2029
4.1.2 Autologous Cellular Immunotherapy
4.1.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy
4.1.4 Dendritic Cell-based Vaccine Therapy
4.2 By Type - Global Cell-Based Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global Cell-Based Immunotherapy Revenue, 2018-2023
4.2.2 By Type - Global Cell-Based Immunotherapy Revenue, 2024-2029
4.2.3 By Type - Global Cell-Based Immunotherapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell-Based Immunotherapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Others
5.2 By Application - Global Cell-Based Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global Cell-Based Immunotherapy Revenue, 2018-2023
5.2.2 By Application - Global Cell-Based Immunotherapy Revenue, 2024-2029
5.2.3 By Application - Global Cell-Based Immunotherapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cell-Based Immunotherapy Market Size, 2022 & 2029
6.2 By Region - Global Cell-Based Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global Cell-Based Immunotherapy Revenue, 2018-2023
6.2.2 By Region - Global Cell-Based Immunotherapy Revenue, 2024-2029
6.2.3 By Region - Global Cell-Based Immunotherapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cell-Based Immunotherapy Revenue, 2018-2029
6.3.2 US Cell-Based Immunotherapy Market Size, 2018-2029
6.3.3 Canada Cell-Based Immunotherapy Market Size, 2018-2029
6.3.4 Mexico Cell-Based Immunotherapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cell-Based Immunotherapy Revenue, 2018-2029
6.4.2 Germany Cell-Based Immunotherapy Market Size, 2018-2029
6.4.3 France Cell-Based Immunotherapy Market Size, 2018-2029
6.4.4 U.K. Cell-Based Immunotherapy Market Size, 2018-2029
6.4.5 Italy Cell-Based Immunotherapy Market Size, 2018-2029
6.4.6 Russia Cell-Based Immunotherapy Market Size, 2018-2029
6.4.7 Nordic Countries Cell-Based Immunotherapy Market Size, 2018-2029
6.4.8 Benelux Cell-Based Immunotherapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cell-Based Immunotherapy Revenue, 2018-2029
6.5.2 China Cell-Based Immunotherapy Market Size, 2018-2029
6.5.3 Japan Cell-Based Immunotherapy Market Size, 2018-2029
6.5.4 South Korea Cell-Based Immunotherapy Market Size, 2018-2029
6.5.5 Southeast Asia Cell-Based Immunotherapy Market Size, 2018-2029
6.5.6 India Cell-Based Immunotherapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cell-Based Immunotherapy Revenue, 2018-2029
6.6.2 Brazil Cell-Based Immunotherapy Market Size, 2018-2029
6.6.3 Argentina Cell-Based Immunotherapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell-Based Immunotherapy Revenue, 2018-2029
6.7.2 Turkey Cell-Based Immunotherapy Market Size, 2018-2029
6.7.3 Israel Cell-Based Immunotherapy Market Size, 2018-2029
6.7.4 Saudi Arabia Cell-Based Immunotherapy Market Size, 2018-2029
6.7.5 UAE Cell-Based Immunotherapy Market Size, 2018-2029
7 Cell-Based Immunotherapy Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Cell-Based Immunotherapy Major Product Offerings
7.1.4 Novartis Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Cell-Based Immunotherapy Major Product Offerings
7.2.4 Gilead Sciences Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Cell-Based Immunotherapy Major Product Offerings
7.3.4 AbbVie Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Cell-Based Immunotherapy Major Product Offerings
7.4.4 Bristol-Myers Squibb Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Amgen
7.5.1 Amgen Company Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Cell-Based Immunotherapy Major Product Offerings
7.5.4 Amgen Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.5.5 Amgen Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Cell-Based Immunotherapy Major Product Offerings
7.6.4 AstraZeneca Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Biogen
7.7.1 Biogen Company Summary
7.7.2 Biogen Business Overview
7.7.3 Biogen Cell-Based Immunotherapy Major Product Offerings
7.7.4 Biogen Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.7.5 Biogen Key News & Latest Developments
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Company Summary
7.8.2 Boehringer Ingelheim Business Overview
7.8.3 Boehringer Ingelheim Cell-Based Immunotherapy Major Product Offerings
7.8.4 Boehringer Ingelheim Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.8.5 Boehringer Ingelheim Key News & Latest Developments
7.9 Eli Lilly and Company
7.9.1 Eli Lilly and Company Company Summary
7.9.2 Eli Lilly and Company Business Overview
7.9.3 Eli Lilly and Company Cell-Based Immunotherapy Major Product Offerings
7.9.4 Eli Lilly and Company Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.9.5 Eli Lilly and Company Key News & Latest Developments
7.10 GSK
7.10.1 GSK Company Summary
7.10.2 GSK Business Overview
7.10.3 GSK Cell-Based Immunotherapy Major Product Offerings
7.10.4 GSK Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.10.5 GSK Key News & Latest Developments
7.11 Pfizer
7.11.1 Pfizer Company Summary
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Cell-Based Immunotherapy Major Product Offerings
7.11.4 Pfizer Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.11.5 Pfizer Key News & Latest Developments
7.12 Roche
7.12.1 Roche Company Summary
7.12.2 Roche Business Overview
7.12.3 Roche Cell-Based Immunotherapy Major Product Offerings
7.12.4 Roche Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.12.5 Roche Key News & Latest Developments
7.13 Takara Bio
7.13.1 Takara Bio Company Summary
7.13.2 Takara Bio Business Overview
7.13.3 Takara Bio Cell-Based Immunotherapy Major Product Offerings
7.13.4 Takara Bio Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.13.5 Takara Bio Key News & Latest Developments
7.14 Bausch Health
7.14.1 Bausch Health Company Summary
7.14.2 Bausch Health Business Overview
7.14.3 Bausch Health Cell-Based Immunotherapy Major Product Offerings
7.14.4 Bausch Health Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.14.5 Bausch Health Key News & Latest Developments
7.15 Apac Biotech
7.15.1 Apac Biotech Company Summary
7.15.2 Apac Biotech Business Overview
7.15.3 Apac Biotech Cell-Based Immunotherapy Major Product Offerings
7.15.4 Apac Biotech Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.15.5 Apac Biotech Key News & Latest Developments
7.16 Dendreon Pharmaceuticals (SanPower)
7.16.1 Dendreon Pharmaceuticals (SanPower) Company Summary
7.16.2 Dendreon Pharmaceuticals (SanPower) Business Overview
7.16.3 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Major Product Offerings
7.16.4 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.16.5 Dendreon Pharmaceuticals (SanPower) Key News & Latest Developments
7.17 JW CreaGene
7.17.1 JW CreaGene Company Summary
7.17.2 JW CreaGene Business Overview
7.17.3 JW CreaGene Cell-Based Immunotherapy Major Product Offerings
7.17.4 JW CreaGene Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.17.5 JW CreaGene Key News & Latest Developments
7.18 Green Cross Corp
7.18.1 Green Cross Corp Company Summary
7.18.2 Green Cross Corp Business Overview
7.18.3 Green Cross Corp Cell-Based Immunotherapy Major Product Offerings
7.18.4 Green Cross Corp Cell-Based Immunotherapy Revenue in Global Market (2018-2023)
7.18.5 Green Cross Corp Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cell-Based Immunotherapy Market Opportunities & Trends in Global Market
Table 2. Cell-Based Immunotherapy Market Drivers in Global Market
Table 3. Cell-Based Immunotherapy Market Restraints in Global Market
Table 4. Key Players of Cell-Based Immunotherapy in Global Market
Table 5. Top Cell-Based Immunotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cell-Based Immunotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cell-Based Immunotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cell-Based Immunotherapy Product Type
Table 9. List of Global Tier 1 Cell-Based Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell-Based Immunotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cell-Based Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cell-Based Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cell-Based Immunotherapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cell-Based Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cell-Based Immunotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cell-Based Immunotherapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cell-Based Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cell-Based Immunotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cell-Based Immunotherapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cell-Based Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cell-Based Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cell-Based Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cell-Based Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cell-Based Immunotherapy Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Cell-Based Immunotherapy Product Offerings
Table 32. Novartis Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Gilead Sciences Company Summary
Table 35. Gilead Sciences Cell-Based Immunotherapy Product Offerings
Table 36. Gilead Sciences Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. Gilead Sciences Key News & Latest Developments
Table 38. AbbVie Company Summary
Table 39. AbbVie Cell-Based Immunotherapy Product Offerings
Table 40. AbbVie Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. AbbVie Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb Cell-Based Immunotherapy Product Offerings
Table 44. Bristol-Myers Squibb Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
Table 46. Amgen Company Summary
Table 47. Amgen Cell-Based Immunotherapy Product Offerings
Table 48. Amgen Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Cell-Based Immunotherapy Product Offerings
Table 52. AstraZeneca Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Biogen Company Summary
Table 55. Biogen Cell-Based Immunotherapy Product Offerings
Table 56. Biogen Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 57. Biogen Key News & Latest Developments
Table 58. Boehringer Ingelheim Company Summary
Table 59. Boehringer Ingelheim Cell-Based Immunotherapy Product Offerings
Table 60. Boehringer Ingelheim Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 61. Boehringer Ingelheim Key News & Latest Developments
Table 62. Eli Lilly and Company Company Summary
Table 63. Eli Lilly and Company Cell-Based Immunotherapy Product Offerings
Table 64. Eli Lilly and Company Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 65. Eli Lilly and Company Key News & Latest Developments
Table 66. GSK Company Summary
Table 67. GSK Cell-Based Immunotherapy Product Offerings
Table 68. GSK Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 69. GSK Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Cell-Based Immunotherapy Product Offerings
Table 72. Pfizer Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 73. Pfizer Key News & Latest Developments
Table 74. Roche Company Summary
Table 75. Roche Cell-Based Immunotherapy Product Offerings
Table 76. Roche Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 77. Roche Key News & Latest Developments
Table 78. Takara Bio Company Summary
Table 79. Takara Bio Cell-Based Immunotherapy Product Offerings
Table 80. Takara Bio Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 81. Takara Bio Key News & Latest Developments
Table 82. Bausch Health Company Summary
Table 83. Bausch Health Cell-Based Immunotherapy Product Offerings
Table 84. Bausch Health Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 85. Bausch Health Key News & Latest Developments
Table 86. Apac Biotech Company Summary
Table 87. Apac Biotech Cell-Based Immunotherapy Product Offerings
Table 88. Apac Biotech Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 89. Apac Biotech Key News & Latest Developments
Table 90. Dendreon Pharmaceuticals (SanPower) Company Summary
Table 91. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product Offerings
Table 92. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 93. Dendreon Pharmaceuticals (SanPower) Key News & Latest Developments
Table 94. JW CreaGene Company Summary
Table 95. JW CreaGene Cell-Based Immunotherapy Product Offerings
Table 96. JW CreaGene Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 97. JW CreaGene Key News & Latest Developments
Table 98. Green Cross Corp Company Summary
Table 99. Green Cross Corp Cell-Based Immunotherapy Product Offerings
Table 100. Green Cross Corp Cell-Based Immunotherapy Revenue (US$, Mn) & (2018-2023)
Table 101. Green Cross Corp Key News & Latest Developments
List of Figures
Figure 1. Cell-Based Immunotherapy Segment by Type in 2022
Figure 2. Cell-Based Immunotherapy Segment by Application in 2022
Figure 3. Global Cell-Based Immunotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cell-Based Immunotherapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cell-Based Immunotherapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell-Based Immunotherapy Revenue in 2022
Figure 8. By Type - Global Cell-Based Immunotherapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cell-Based Immunotherapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cell-Based Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cell-Based Immunotherapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cell-Based Immunotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cell-Based Immunotherapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cell-Based Immunotherapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cell-Based Immunotherapy Revenue Market Share, 2018-2029
Figure 16. US Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cell-Based Immunotherapy Revenue Market Share, 2018-2029
Figure 20. Germany Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cell-Based Immunotherapy Revenue Market Share, 2018-2029
Figure 28. China Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cell-Based Immunotherapy Revenue Market Share, 2018-2029
Figure 34. Brazil Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cell-Based Immunotherapy Revenue Market Share, 2018-2029
Figure 37. Turkey Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cell-Based Immunotherapy Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Gilead Sciences Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AbbVie Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Amgen Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Biogen Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Boehringer Ingelheim Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Eli Lilly and Company Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. GSK Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Pfizer Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Roche Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Takara Bio Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Bausch Health Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Apac Biotech Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. JW CreaGene Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Green Cross Corp Cell-Based Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
